Hypoglycemia (<54 mg/dL or severe) was reported in five (1%) patients at the 5 mg dose, four (1%) at the 10 mg dose, and eight (2%) at the 15 mg dose, compared with 26 (7%) to insulin degludec. The gene discussed is INS; the disease is Hypoglycemia.